Lifeloc Technologies, Inc. (OTC: LCTC), a global leader in the development and manufacturing of breath alcohol testing devices, has announced financial results for the 2018 fiscal year ended December 31, 2018.
2018 Financial Highlights
Lifeloc Technologies posted annual net revenue of $8.44 million resulting in 2018 after tax net income of $217 thousand, or $0.09 per diluted share. These results compare to net revenue of $7.99 million for 2017 full year, with net income of $15 thousand, or $0.01 per diluted share. Revenue for 2018 grew 6% over the prior year. Our balance sheet grew even stronger, with a growth in cash of $119 thousand and a debt reduction of $40 thousand.
This has been a transitional year for Lifeloc Technologies. In 2018 we made a significant investment in the upgrade of our enterprise resource planning (ERP) information infrastructure for improved efficiency and to handle a broadening product line. This has already contributed some sales growth through the upgraded e-Commerce portal. We are completing a multiyear R&D investment for the development of a completely new breathalyzer platform that will be introduced in 2019. And as these projects wind down, freed resources will be deployed to accelerating the development of our rapid drug detection based on the SpinDx„¢ technology, including a rapid, quantitative marijuana breathalyzer, as well as advancing our monitoring business, primarily through the Real-Time Alcohol Detection and Recognition (R.A.D.A.R.) device.
Our vision is that Lifeloc becomes the worlds leading company in real-time alcohol and drug abuse detection and monitoring. To that end, we continue to invest aggressively in research and development. This R&D investment amounted to over 13% of revenue for the year. Lifeloc is committed to bringing the most advanced alcohol breathalyzers, alcohol monitoring devices and marijuana breathalyzers to the market.
We are glad to return to a year of growth, having achieved some modest revenue growth in 2018 through improving sales channels, even though there were no new product introductions this year, commented Dr. Wayne Willkomm, President and CEO. 2019 will be different, with a pipeline of new breathalyzer and affiliated launches which will deliver more performance and value to our customers.
In addition to operational investments, Lifeloc Technologies is pleased to announce that the Depository Trust Corporation (the “DTC”) has approved its common stock for DWAC/FAST transfer through the Company’s Transfer Agent, Corporate Stock Transfer, Inc. This newly approved stock transfer capability will enable Lifeloc’s shareholders to transfer their shares of Lifeloc stock electronically after buying or selling, without the extra cost and burden associated with the processing of physical share certificates.
DWAC/FAST transfer expedites the transaction process, while also eliminating the risks associated with the loss and replacement of physical share certificates. “We are pleased to facilitate easier trading for our shareholders,” said Dr. Willkomm. “Not only does becoming DWAC/FAST eligible provide our existing shareholders with new efficiencies, but we hope for more liquidity and better valuation in the open market, allowing us to continue expanding our shareholder base,” he added.
About Lifeloc Technologies
Lifeloc Technologies, Inc. (OTC: LCTC) is a trusted U.S. manufacturer of evidential breath alcohol testers and related training and supplies for Workplace, Law Enforcement, Corrections and International customers. Lifeloc stock trades over-the-counter under the symbol LCTC. We are a fully reporting Company with our SEC filings available on our web site, www.lifeloc.com.
Forward Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. All forward-looking statements expressed or implied in this press release, including statements about our strategies, expectations about new and existing products, market demand, acceptance of new and existing products, technologies and opportunities, market size and growth, and return on investments in products and market, are based on information available to us on the date of this document, and we assume no obligation to update such forward-looking statements. Investors are strongly encouraged to review the section titled Risk Factors in our SEC filings.
R.A.D.A.R. is a registered trademark of Lifeloc Technologies, Inc.
SpinDx„¢ is a trademark of Sandia Corporation.
|LIFELOC TECHNOLOGIES, INC.|
|Cash and cash equivalents||$||2,788,327||$||2,669,455|
|Accounts receivable, net||675,136||593,326|
|Income taxes receivable||90,629||121,401|
|Prepaid expenses and other||35,155||21,804|
|Total current assets||4,879,854||4,581,089|
|PROPERTY AND EQUIPMENT, at cost:|
|Real-time Alcohol Detection And Recognition equipment and software||569,448||569,448|
|Production equipment and software||800,569||556,025|
|Office equipment and software||241,836||204,282|
|Sales and marketing equipment||219,797||216,330|
|Research and development equipment and software||159,810||131,770|
|Less accumulated depreciation||(1,649,203||)||(1,349,499||)|
|Total property and equipment, net||3,021,359||3,007,458|
|Deposits and other||140,452||259,037|
|Total other assets||378,468||502,812|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|Term loan payable, current portion||43,207||42,101|
|Deferred revenue, current portion||44,218||53,137|
|Reserve for warranty expense||40,000||40,000|
|Total current liabilities||741,385||745,387|
|TERM LOAN PAYABLE, net of current portion and|
|debt issuance costs||1,369,347||1,410,185|
|DEFERRED REVENUE, net of current portion||8,212||9,683|
|COMMITMENTS AND CONTINGENCIES|
|Common stock, no par value; 50,000,000 shares|
|authorized, 2,454,116 shares outstanding||4,597,646||4,580,177|
|Total stockholders’ equity||6,160,737||5,926,104|
|Total liabilities and stockholders’ equity||$||8,279,681||$||8,091,359|
|LIFELOC TECHNOLOGIES, INC.|
|Statements of Income|
|Years Ended December 31,|
|COST OF SALES||4,628,403||4,277,874|
|Research and development||1,121,827||1,076,763|
|Sales and marketing||1,251,388||1,388,927|
|General and administrative||1,165,413||1,114,534|
|OTHER INCOME (EXPENSE):|
|NET INCOME BEFORE PROVISION FOR TAXES||234,597||78,759|
|(PROVISION FOR) FEDERAL AND STATE INCOME TAXES|
|NET INCOME PER SHARE, BASIC||$||0.09||$||0.01|
|NET INCOME PER SHARE, DILUTED||$||0.09||$||0.01|
|WEIGHTED AVERAGE SHARES, BASIC||2,454,116||2,454,116|
|WEIGHTED AVERAGE SHARES, DILUTED||2,512,445||2,518,188|
|LIFELOC TECHNOLOGIES, INC.|
|Statements of Cash Flows|
|Years Ended December 31,|
|CASH FLOWS FROM OPERATING ACTIVITIES:||2018||2017|
|Adjustments to reconcile net income to net cash|
|provided from (used in) operating activities-|
|Depreciation and amortization||416,896||288,017|
|Provision for doubtful accounts, net change||(5,000||)||–|
|Provision for inventory obsolescence, net change||60,000||27,500|
|Deferred taxes, net change||(13,338||)||43,196|
|Reserve for warranty expense, net change||–||–|
|Stock based compensation expense related to|
|Changes in operating assets and liabilities-|
|Income taxes receivable||30,772||(6,728||)|
|Prepaid expenses and other||(13,351||)||30,268|
|Deposits and other||118,585||(160,046||)|
|Net cash provided from (used in)|
|CASH FLOWS FROM INVESTING ACTIVITIES:|
|Purchases of property and equipment||(402,147||)||(11,846||)|
|Cash paid for equipment and software acquired|
|in asset acquisition||–||(748,198||)|
|Cash paid for patents and patent applications acquired|
|in asset acquisition||–||(100,000||)|
|Patent filing expense||(6,750||)||(17,217||)|
|Net cash (used in) investing activities||(408,897||)||(877,261||)|
|CASH FLOWS FROM FINANCING ACTIVITIES:|
|Principal payments made on term loan||(42,535||)||(44,079||)|
|Net cash (used in) financing|
|NET INCREASE (DECREASE) IN CASH||118,872||(1,102,609||)|
|CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD||2,669,455||3,772,064|
|CASH AND CASH EQUIVALENTS, END OF PERIOD||$||2,788,327||$||2,669,455|
|Cash paid for interest||$||58,847||$||65,348|
|Cash paid for income tax||$||–||$||40,096|
Lifeloc Technologies, Inc.